[go: up one dir, main page]

AU2001267561A1 - Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents - Google Patents

Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents

Info

Publication number
AU2001267561A1
AU2001267561A1 AU2001267561A AU6756101A AU2001267561A1 AU 2001267561 A1 AU2001267561 A1 AU 2001267561A1 AU 2001267561 A AU2001267561 A AU 2001267561A AU 6756101 A AU6756101 A AU 6756101A AU 2001267561 A1 AU2001267561 A1 AU 2001267561A1
Authority
AU
Australia
Prior art keywords
acid derivatives
phosphonic acid
acetylhydroxylaminopropyl
active agents
formylhydroxylaminopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267561A
Other languages
English (en)
Inventor
Hassan Jomaa
Jochen Wiesner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jomaa Pharmaka GmbH
Original Assignee
Jomaa Pharmaka GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka GmbH filed Critical Jomaa Pharmaka GmbH
Publication of AU2001267561A1 publication Critical patent/AU2001267561A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU2001267561A 2000-06-29 2001-06-23 Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents Abandoned AU2001267561A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10030781 2000-06-29
DE10030781A DE10030781A1 (de) 2000-06-29 2000-06-29 Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
PCT/EP2001/007140 WO2002000208A2 (fr) 2000-06-29 2001-06-23 Preparations de derives d'acide 3-n-formylhydroxylaminopropylphosphonique ou de derives d'acide 3-n-acetylhydroxylaminopropylphosphonique combines avec des principes actifs pharmaceutiques speciaux

Publications (1)

Publication Number Publication Date
AU2001267561A1 true AU2001267561A1 (en) 2002-01-08

Family

ID=7646647

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267561A Abandoned AU2001267561A1 (en) 2000-06-29 2001-06-23 Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents

Country Status (8)

Country Link
US (2) US20040235784A1 (fr)
EP (1) EP1305031B1 (fr)
AT (1) ATE395064T1 (fr)
AU (1) AU2001267561A1 (fr)
CA (1) CA2420640C (fr)
DE (2) DE10030781A1 (fr)
ES (1) ES2306718T3 (fr)
WO (1) WO2002000208A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088820B2 (en) 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
AU2003287218C1 (en) * 2002-10-24 2010-07-15 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US20070166354A1 (en) 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
US7829126B2 (en) 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
DE102007026176A1 (de) * 2007-01-04 2008-07-17 Dewind Ltd. SCADA-Einheit
FR2914860B1 (fr) * 2007-04-12 2009-05-22 Ile D Inventeurs Apis Spheromo Spheroides multicouches a action antipaludique dont l'une des couches contient de l'artesunate
EP2404601A1 (fr) * 2010-07-06 2012-01-11 BioAgency AG Nouvelles combinaisons de médicaments pour le traitement du paludisme
EP3235815A1 (fr) 2016-04-19 2017-10-25 Philipps-Universität Marburg Agents actifs contre les helminthes parasites
EP4045056A1 (fr) 2019-10-19 2022-08-24 DMG Deutsche Malaria GmbH Préparations combinées de dérivés d'acide 3-n-formylhydroxylaminopropyl phosphonique ou de dérivés d'acide 3-n-acétylhydroxylaminopropyl phosphonique avec de la clindamycine et l'artésunate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715346A (en) * 1970-11-18 1973-02-06 Upjohn Co Process for the preparation of lincomycin compounds
US4330529A (en) * 1978-02-15 1982-05-18 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
JPS5746917A (en) * 1980-09-03 1982-03-17 Fujisawa Pharmaceut Co Ltd Antibacterial agent
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
JPS6064991A (ja) * 1983-09-17 1985-04-13 Fujisawa Pharmaceut Co Ltd セファレキシン・ホスミドマイシン塩およびその製造法
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6127405A (en) * 1998-07-10 2000-10-03 Council Of Scientific And Industrial Research Method for the use of alpha arteether as an anti-bacterial and anti-fungal agent

Also Published As

Publication number Publication date
US20040235784A1 (en) 2004-11-25
ATE395064T1 (de) 2008-05-15
WO2002000208A3 (fr) 2002-06-20
EP1305031B1 (fr) 2008-05-14
CA2420640A1 (fr) 2003-02-26
WO2002000208A2 (fr) 2002-01-03
CA2420640C (fr) 2009-09-01
DE50113974D1 (de) 2008-06-26
ES2306718T3 (es) 2008-11-16
DE10030781A1 (de) 2002-01-17
US20150190418A1 (en) 2015-07-09
EP1305031A2 (fr) 2003-05-02

Similar Documents

Publication Publication Date Title
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
AU2274201A (en) Compounds and compositions for delivering active agents
WO2001090091A8 (fr) Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1
WO2003018059A3 (fr) Preparations combinatoires de derives de propanolamine substitues par aryle avec d'autres principes actifs et leur utilisation
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AU2002328972A1 (en) Piperidine derivatives as antibacterial agents
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
AU2119200A (en) Medicament
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO2002015959A3 (fr) Composes et compositions permettant de distribuer des agents actifs
AU2001261516A1 (en) Semi-solid delivery vehicle and pharmaceutical compositions
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
WO2001034641A8 (fr) Activite antimicrobienne du premier groupe cationique de la lactoferrine humaine
WO2003009859A1 (fr) Immunotherapie pour humains
WO2003007876A3 (fr) Conjugues acide amine-acide gras normal et utilisations therapeutiques
SE0001916D0 (sv) Novel formulation
EP1273301A3 (fr) Préparations pharmaceutiques comprenant des principes actifs susceptibles d'administration illicite
BR0011845A (pt) Complexo farmacêutico
AUPQ647600A0 (en) Pharmaceutical gel composition
WO2002070537A3 (fr) Derives d'acide fusidique